According to 2019 ESC guidelines on acute pulmonary embolism (PE) “percutaneous catheter-directed treatment (CDT) should be considered for patients with high risk PE, in whom thrombolysis is contraindicated or has failed” (IIaC recommendation), and also “is an alternative to rescue thrombolytic therapy for patients with haemodynamic deterioration on anticoagulation treatment. (IIaC recommendation)
EAPCI with ESC Working Group on Pulmonary Circulation and Right Ventricular Function have prepared a short survey on CDT in PE. We would like to ask you to complete this survey and also indicate if you are potentially interested in multicenter collaboration (network, registry) on catheter-directed treatment in acute pulmonary embolism.
Thank you for taking part in this brief survey which will take approximately 3-4 minutes. Let’s remind you of the codes of conduct related to market research among healthcare professionals:
- We comply with the European General Data Protection Regulation (GDPR) 2016/679. Any personal data processed in connection with this survey will be treated confidentially and only used for the purposes of market research. Material and data collected from you will be analysed overall, used internally by the ESC and kept for a maximum of 24 months for analysis and quality control purposes. We take all reasonable care to prevent any unauthorised access to your personal data. We respect your privacy and your right to access, modify, or suppress your personal data. At any time, you can ask to know what personal data is being held. If you have any questions about data protection or require further information, please contact our data protection officer DPO@escardio.org
- You have the right to end your participation in this survey at any time
